0000031462false0000031462us-gaap:CommonStockMember2020-07-242020-07-240000031462ecl:EuroNotesDue2025Member2020-07-242020-07-240000031462ecl:EuroNotesDue2024Member2020-07-242020-07-2400000314622020-07-242020-07-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 24, 2020

ECOLAB INC.

(Exact name of registrant as specified in its charter)

Delaware

1-9328

41-0231510

(State or other jurisdiction
of incorporation)

(Commission
File No.)

(IRS Employer
Identification No.)

1 Ecolab Place, Saint Paul, Minnesota

55102

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code 1-800-232-6522

(Not applicable)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

ECL

New York Stock Exchange

2.625% Euro Notes due 2025

ECL 25

New York Stock Exchange

1.000% Euro Notes due 2024

ECL 24

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02 Results of Operations and Financial Condition.

On June 3, 2020, Ecolab Inc. (“Ecolab” or “the Company”) completed the previously announced separation of its Upstream Energy business (the “ChampionX Business”) in a Reverse Morris Trust transaction (the “Transaction”) through the split-off of ChampionX Holding Inc. (“ChampionX”), formed by Ecolab as a wholly owned subsidiary to hold the ChampionX Business, followed immediately by the merger of ChampionX (the “Merger”) with a wholly owned subsidiary of ChampionX Corporation (f/k/a Apergy Corporation, “Apergy”). As a result of the Transaction, the ChampionX business, which includes the direct revenues, operating expenses and certain other expenses directly attributable to the ChampionX business, is reflected in the Company’s historical financial statements as discontinued operations. The ChampionX business met the criteria to be reported as discontinued operations because it is a strategic shift in business that has a major effect on the Company's operations and financial results. Therefore, the Company is reporting the historical results of ChampionX as discontinued operations for the periods presented.

The Company is providing as an exhibit to this Current Report on Form 8-K a table (Exhibit 99.1) with the unaudited revised consolidated statement of income for the years ended December 31, 2019 and December 31, 2018 reflecting the ChampionX business as discontinued operations.

The Company is also providing a table (Exhibit 99.2) with supplemental unaudited revised consolidated statement of income for each of the three months ended March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, the twelve months ended December 31, 2019 and the three months ended March 31, 2020 reflecting the ChampionX business as discontinued operations.

The Company is also providing a table (Exhibit 99.3) with supplemental unaudited reportable segment net sales and operating income information for the twelve months ended December 31, 2019 and 2018, reflecting the changes noted above.

The Company is also providing a table (Exhibit 99.4) with supplemental unaudited reportable segment net sales and operating income information for each of the three months ended March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, the twelve months ended December 31, 2019, and the three ended March 31, 2020 reflecting the changes noted above.

The Company is also providing certain supplemental unaudited revised adjusted financial measures that have not been calculated in accordance with accounting principles generally accepted in the United States (“non-GAAP measures”), including fixed currency sales, adjusted cost of sales, adjusted gross margin, fixed currency operating income, adjusted fixed currency operating income, adjusted fixed currency operating income margin, adjusted net income, and adjusted diluted EPS (Exhibit 99.5) which reflects the ChampionX business as discontinued operations. These non-GAAP measures are provided as additional information regarding operating results and are used internally to evaluate performance and in making financial and operational decisions, including with respect to incentive compensation. These measures provide investors with greater transparency with respect to the results of operations and are useful for period-to-period comparison of results.

Ecolab also will publish the attached exhibits on its website located at www.ecolab.com.

The tables represent a supplemental presentation of certain of Ecolab’s 2019 and 2018 information as explained in this Current Report on Form 8-K and the tables and are not intended to replace the presentation of such information in Ecolab’s Quarterly Reports on Form 10-Q filed with respect to the first, second and third quarters of 2019 and Ecolab’s Annual Reports on Form 10-K filed with respect to the fiscal years ended December 31, 2019 and December 31, 2018.

The information in this Current Report on Form 8-K, including the exhibits attached hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, except as shall be expressly set forth by specific reference in such a filing.

2

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits.

The following exhibits are furnished pursuant to Item 2.02 of Form 8-K and should not be deemed to be “filed” under the Securities Exchange Act of 1934.

Exhibit No.

Description

Method Of Filing

(99.1)

Supplemental Revised Consolidated Statement of Income for the years ended December 31, 2019 and 2018 (unaudited).

Filed herewith electronically.

(99.2)

Supplemental Revised Consolidated Statement of Income for each of the three month periods ended March 31, June 30, September 30 and December 31, 2019, the twelve months ended December 31, 2019 and the three month period ended March 31, 2020 (unaudited).

Filed herewith electronically.

(99.3)

Supplemental Reportable Segment Information and Non-GAAP Reconciliation (unaudited).

Filed herewith electronically.

(99.4)

Supplemental Reportable Segment Information and Non-GAAP Reconciliation 2020 and 2019 Revised Segment Data at 2020 Fixed Currency Exchange Rates (unaudited).

Filed herewith electronically.

(99.5)

Supplemental Non-GAAP Reconciliations for the three months ended March 31, 2020 and each of the twelve months ended December 31, 2019 and 2018 (unaudited).

Filed herewith electronically.

(104)

Cover Page Interactive Data File.

Embedded within the Inline XBRL document.

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ECOLAB INC.

Date: July 24, 2020

By:

/s/ David F. Duvick

David F. Duvick

Assistant Secretary

4

Exhibit 99.1

ECOLAB INC.

SUPPLEMENTAL REVISED CONSOLIDATED STATEMENT OF INCOME FOR THE
YEARS ENDED DECEMBER 31, 2019 AND 2018

(unaudited)

Year ended December 31 (millions, except per share amounts)

2019

2018

  

Historical Ecolab

  

Discontinued Operations

  

Revised Ecolab

  

Historical Ecolab

  

Discontinued Operations

  

Revised Ecolab

Product and equipment sales

$12,238.9

$(2,109.9)

$10,129.0

$12,128.6

$(2,225.0)

$9,903.6

Service and lease sales

 

2,667.4

(234.4)

2,433.0

2,539.6

(221.1)

2,318.5

Net sales

 

14,906.3

(2,344.3)

12,562.0

14,668.2

(2,446.1)

12,222.1

Product and equipment cost of sales

7,106.4

(1,488.9)

5,617.5

7,078.5

(1,567.9)

5,510.6

Service and lease sales

 

1,617.0

(188.7)

1,428.3

1,547.4

(182.7)

1,364.7

Cost of sales (including special charges (a))

 

8,723.4

(1,677.6)

7,045.8

8,625.9

(1,750.6)

6,875.3

Selling, general, and administrative expenses

 

3,957.5

(406.7)

3,550.8

3,968.6

(462.8)

3,505.8

Special (gains) and charges

 

211.6

(91.4)

120.2

126.7

(14.0)

112.7

Operating income

 

2,013.8

(168.6)

1,845.2

1,947.0

(218.7)

1,728.3

Other (income) expense (including special charges (b))

 

(76.3)

(0.7)

(77.0)

(79.9)

-

(79.9)

Interest expense, net (including special charges (c))

191.2

(0.5)

190.7

222.3

(1.2)

221.1

Income before income taxes

 

1,898.9

(167.4)

1,731.5

1,804.6

(217.5)

1,587.1

Provision for income taxes

322.7

(34.1)

288.6

364.3

(43.1)

321.2

Net income from continuing operations, including noncontrolling interest

1,576.2

(133.3)

1,442.9

1,440.3

(174.4)

1,265.9

Net income from continuing operations attributable to noncontrolling interest

17.3

-

17.3

11.2

4.4

15.6

Net income from continuing operations attributable to Ecolab

1,558.9

(133.3)

1,425.6

1,429.1

(178.8)

1,250.3

Net income from discontinued operations, net of tax

-

133.3

133.3

-

178.8

178.8

Net income attributable to Ecolab

$1,558.9

$-

$1,558.9

$1,429.1

$-

$1,429.1

Earnings attributable to Ecolab per common share

Basic

Continuing operations

$4.95

$4.33

Discontinued operations

$0.46

$0.62

Earnings attributable to Ecolab

$5.41

$5.41

$4.95

$4.95

Diluted

Continuing operations

$4.87

$4.27

Discontinued operations

$0.46

$0.61

Earnings attributable to Ecolab

$5.33

$5.33

$4.88

$4.88

Weighted-average common shares outstanding

Basic

288.1

288.1

288.6

288.6

Diluted

292.5

292.5

292.8

292.8

(a)For 2019, both historical Ecolab and revised Ecolab cost of sales includes $38.5 of special (gains) and charges, net recorded in product and equipment cost of sales. No special charges are recorded in cost of sales from discontinued operations. For 2018, historical Ecolab reported cost of sales includes special (gains) and charges, net of $9.3 recorded in product and equipment cost of sales. For revised Ecolab, cost of sales includes special (gains) and charges, net of $4.8 recorded in product and equipment cost of sales. Discontinued operations includes special (gains) and charges, net of $4.5 recorded in cost of sales.
(b)For 2019 both historical and revised Ecolab, other (income) expense includes special charges of $9.5. No special charges are recorded in other (income) expense from discontinued operations.
(c)Both historical and revised Ecolab interest expense, net includes special charges of $0.2 and $0.3 in 2019 and 2018, respectively. No special charges are recorded in interest expense, net from discontinued operations.

Notes:

On June 3, 2020, the Company completed the previously announced separation of its Upstream Energy business (the “ChampionX Business”) in a Reverse Morris Trust transaction (the “Transaction”) through the split-off of ChampionX Holding Inc. (“ChampionX”), formed by Ecolab as a wholly owned subsidiary to hold the ChampionX Business, followed immediately by the merger of ChampionX (the “Merger”) with a wholly owned subsidiary of ChampionX Corporation (f/k/a Apergy Corporation, “Apergy”). The ChampionX business met the criteria to be reported as discontinued operations because it is a strategic shift in business that has a major effect on the Company's operations and financial results. Therefore, the Company is reporting the historical results of ChampionX as discontinued operations for the periods presented.


Exhibit 99.2

ECOLAB INC.

SUPPLEMENTAL REVISED CONSOLIDATED STATEMENT OF INCOME FOR EACH OF THE
THREE MONTH PERIODS ENDED MARCH 31, JUNE 30, SEPTEMBER 30 AND
DECEMBER 31, 2019, THE TWELVE MONTHS ENDED DECEMBER 31, 2019 AND THE
THREE MONTH PERIOD ENDED MARCH 31, 2020

(unaudited)

(millions)

2019

2020

Three Months Ended
March 31

Three Months Ended
June 30

Three Months Ended
September 30

Three Months Ended
December 31

Twelve Months Ended
December 31

Three Months Ended
March 31

Product and equipment sales

$2,359.8

$2,560.0

$2,591.8

$2,617.4

$10,129.0

$2,424.0

Service and lease sales

564.9

609.1

632.2

626.8

2,433.0

596.6

Net sales

2,924.7

3,169.1

 

3,224.0

3,244.2

12,562.0

3,020.6

Product and equipment cost of sales

1,340.6

1,422.1

1,413.0

1,441.8

5,617.5

1,364.7

Service and lease sales

334.9

358.2

367.9

367.3

1,428.3

355.5

Cost of sales (including special charges (a))

1,675.5

1,780.3

 

1,780.9

1,809.1

7,045.8

1,720.2

Selling, general, and administrative expenses

896.1

900.0

869.2

885.5

3,550.8

908.3

Special (gains) and charges

39.5

24.4

24.9

31.4

120.2

15.9

Operating income

313.6

464.4

549.0

518.2

1,845.2

376.2

Other (income) expense (including special charges (b))

(21.2)

(20.9)

(20.8)

(14.1)

(77.0)

(15.4)

Interest expense, net (including special charges (c))

49.3

49.2

46.1

46.1

190.7

48.3

Income before income taxes

285.5

436.1

523.7

486.2

1,731.5

343.3

Provision for income taxes

29.9

88.8

83.4

86.5

288.6

47.0

Net income from continuing operations, including noncontrolling interest

255.6

347.3

440.3

399.7

1,442.9

296.3

Net income from continuing operations attributable to noncontrolling interest

4.0

3.9

4.4

5.0

17.3

4.3

Net income from continuing operations attributable to Ecolab

251.6

343.4

435.9

394.7

1,425.6

292.0

Net income from discontinued operations, net of tax

44.9

25.2

28.3

34.9

133.3

(8.6)

Net income attributable to Ecolab

$296.5

$368.6

$464.2

$429.6

$1,558.9

$283.4

Earnings attributable to Ecolab per common share

Basic

Continuing operations

$0.87

$1.19

$1.51

$1.37

$4.95

$1.01

Discontinued operations

$0.16

$0.09

$0.10

$0.12

$0.46

($0.03)

Earnings attributable to Ecolab

$1.03

$1.28

$1.61

$1.49

$5.41

$0.98

Diluted

Continuing operations

$0.86

$1.18

$1.49

$1.35

$4.87

$1.00

Discontinued operations

$0.15

$0.08

$0.10

$0.12

$0.46

($0.03)

Earnings attributable to Ecolab

$1.01

$1.26

$1.59

$1.47

$5.33

$0.97

Weighted-average common shares outstanding

Basic

288.2

287.6

288.1

288.3

288.1

288.8

Diluted

292.3

292.1

292.8

292.6

292.5

292.6

Diluted Earnings per Share from continuing operations attributable to Ecolab

GAAP diluted EPS from continuing operations

$0.86

$1.18

$1.49

$1.35

$4.87

$1.00

Special (gains) and charges, after tax

0.11

0.09

0.08

0.16

0.44

0.06

Discrete tax net expense (benefit)

(0.09)

-

(0.05)

(0.06)

(0.20)

(0.07)

Non-GAAP adjusted diluted EPS from continuing operations

$0.88

$1.27

$1.52

$1.45

$5.12

$0.99

(a)Total cost of sales includes special charges of $3.6, $7.9, $11.3, and $15.7 in the three months ended March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, respectively, and $9.1 in the three months ended March 31, 2020 which are recorded in Product and equipment cost of sales.
(b)Other (income) expense includes special charges of $9.5 in the three months ended December 31, 2019.
(c)Net interest expense includes special charges of $0.2 in the three months ended March 31, 2019.


Notes:

Per share amounts do not necessarily sum due to rounding.

The revised Consolidated Statement of Income for each of the three months ended March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019, the twelve months ended December 31, 2019 and the three months ended March 31, 2020 reflect the historical results of ChampionX as discontinued operations for the periods presented.

The revised diluted earnings per share (“EPS”) table includes financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”), including revised non-GAAP adjusted diluted EPS. The table above provides a reconciliation of diluted earnings per share, as revised, to the non-GAAP measure of adjusted diluted earnings per share. We use this non-GAAP measure internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of this measure provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results. This non-GAAP financial measure is not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view this measure in conjunction with the GAAP measure included in the table.


Exhibit 99.3

ECOLAB INC.

SUPPLEMENTAL REPORTABLE SEGMENT INFORMATION

AND NON-GAAP RECONCILIATION

(unaudited)

(millions)

Three Months Ended March 31, 2020

2020 Reported Valued at 2020 Management Rates

Discontinued Operations and Related Allocation Changes

2020 Continuing Operations Valued at 2020 Management Rates

Net Sales

Global Industrial

$1,444.0

$(0.4)

$1,443.6

Global Institutional

1,072.3

 

(0.2)

1,072.1

Global Healthcare and Life Sciences

246.2

 

0.3

246.5

Upstream Energy

562.7

(562.7)

-

Other

277.8

 

(0.2)

277.6

Subtotal at fixed currency

3,603.0

(563.2)

3,039.8

Effect of foreign currency translation

(21.6)

2.4

(19.2)

Total reported GAAP net sales

$3,581.4

$(560.8)

$3,020.6

Operating Income

Global Industrial

$226.9

$(20.3)

$206.6

Global Institutional

183.5

(1.1)

182.4

Global Healthcare and Life Sciences

25.6

(2.7)

22.9

Upstream Energy

39.0

(39.0)

-

Other

25.3

(3.7)

21.6

Corporate

(100.2)

45.6

(54.6)

Subtotal at fixed currency

400.1

(21.2)

378.9

Effect of foreign currency translation

(2.9)

0.2

(2.7)

Total reported GAAP operating income

$397.2

$(21.0)

$376.2

Twelve Months Ended December 31, 2019

2019 Reported Valued at 2020 Management Rates

Discontinued Operations and Related Allocation Changes

2019 Continuing Operations Valued at 2020 Management Rates

Net Sales

Global Industrial

$5,996.4

$(1.8)

$5,994.6

Global Institutional

4,412.1

 

-

4,412.1

Global Healthcare and Life Sciences

979.0

 

-

979.0

Upstream Energy

2,352.9

(2,352.9)

-

Other

1,211.7

 

-

1,211.7

Subtotal at fixed currency

14,952.1

(2,354.7)

12,597.4

Effect of foreign currency translation

(45.8)

10.4

(35.4)

Total reported GAAP net sales

$14,906.3

$(2,344.3)

$12,562.0

Operating Income

Global Industrial

$980.6

$(77.9)

$902.7

Global Institutional

947.3

(7.5)

939.8

Global Healthcare and Life Sciences

135.1

(10.6)

124.5

Upstream Energy

187.9

(187.9)

-

Other

180.6

(13.6)

167.0

Corporate

(407.9)

128.2

(279.7)

Subtotal at fixed currency

2,023.6

(169.3)

1,854.3

Effect of foreign currency translation

(9.8)

0.7

(9.1)

Total reported GAAP operating income

$2,013.8

$(168.6)

$1,845.2

Twelve Months Ended December 31, 2018

2018 Reported Valued at 2020 Management Rates

Discontinued Operations and Related Allocation Changes

2018 Continuing Operations Valued at 2020 Management Rates

Net Sales

Global Industrial

$5,690.3

$(1.8)

$5,688.5

Global Institutional

4,255.2

 

-

4,255.2

Global Healthcare and Life Sciences

915.7

 

-

915.7

Upstream Energy

2,422.3

(2,422.3)

-

Other

1,155.3

 

-

1,155.3

Subtotal at fixed currency

14,438.8

(2,424.1)

12,014.7

Effect of foreign currency translation

229.4

(22.0)

207.4

Total reported GAAP net sales

$14,668.2

$(2,446.1)

$12,222.1

Operating Income

Global Industrial

$834.0

$(80.3)

$753.7

Global Institutional

905.0

(3.5)

901.5

Global Healthcare and Life Sciences

135.1

(10.7)

124.4

Upstream Energy

172.3

(172.3)

-

Other

174.6

(10.6)

164.0

Corporate

(302.7)

60.9

(241.8)

Subtotal at fixed currency

1,918.3

(216.5)

1,701.8

Effect of foreign currency translation

28.7

(2.2)

26.5

Total reported GAAP operating income

$1,947.0

$(218.7)

$1,728.3


Notes:

On June 3, 2020, Ecolab Inc. (“Ecolab” or “the Company”) completed the previously announced separation of its Upstream Energy business (the “ChampionX Business”) in a Reverse Morris Trust transaction (the “Transaction”) through the split-off of ChampionX Holding Inc. (“ChampionX”), formed by Ecolab as a wholly owned subsidiary to hold the ChampionX Business, followed immediately by the merger of ChampionX (the “Merger”) with a wholly owned subsidiary of ChampionX Corporation (f/k/a Apergy Corporation, “Apergy”). As a result of the Transaction, the ChampionX business, which includes the direct revenues, operating expenses and certain other expenses directly attributable to the ChampionX business, is reflected in the Company’s historical financial statements as discontinued operations. Allocations of Ecolab’s overhead expenses included in historical Upstream Energy segment results are reallocated to the remaining segments.

Consistent with internal management reporting, Corporate expense amounts include intangible asset amortization specifically from the Nalco merger and special (gains) and charges that are not allocated to our reportable segments.

We evaluate the performance of our non-U.S. dollar functional currency international operations based on fixed currency exchange rates, which eliminate the impact of exchange rate fluctuations on our international operations. Fixed currency rates are generally based on existing market rates at the time they are established.

The above table includes financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”), including fixed currency sales and fixed currency operating income. We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results. These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in the table.


Exhibit 99.4

ECOLAB INC.

SUPPLEMENTAL REPORTABLE SEGMENT INFORMATION AND NON-GAAP RECONCILIATION

2020 AND 2019 REVISED SEGMENT DATA AT 2020 FIXED CURRENCY EXCHANGE RATES

(unaudited)

(millions)

2019

2020

    

Three Months Ended
March 31

Three Months Ended
June 30

Three Months Ended September 30

Three Months Ended December 31

Twelve Months Ended
December 31

Three Months Ended
March 31

Net Sales

Global Industrial

$1,397.0

$1,500.7

$1,517.1

$1,579.8

$5,994.6

$1,443.6

Global Institutional

 

1,020.2

1,112.5

1,150.6

1,128.8

4,412.1

1,072.1

Global Healthcare and Life Sciences

 

227.0

252.8

243.9

255.3

979.0

246.5

Other

 

274.7

306.2

323.1

307.7

1,211.7

277.6

Subtotal at fixed currency

 

2,918.9

3,172.2

3,234.7

 

3,271.6

12,597.4

3,039.8

Effect of foreign currency translation

 

5.8

(3.1)

(10.7)

 

(27.4)

(35.4)

(19.2)

Total reported GAAP net sales

 

$2,924.7

$3,169.1

$3,224.0

$3,244.2

$12,562.0

$3,020.6

    

Operating Income

Global Industrial

$161.4

$220.9

$249.8

$270.6

902.7

$206.6

Global Institutional

 

174.8

234.4

280.9

 

249.7

939.8

182.4

Global Healthcare and Life Sciences

 

24.8

31.2

36.3

 

32.2

124.5

22.9

Other

 

25.7

41.9

51.4

 

48.0

167.0

21.6

Corporate

 

(73.4)

(62.7)

(66.5)

 

(77.1)

(279.7)

(54.6)

Subtotal at fixed currency

 

313.3

465.7

551.9

 

523.4

1,854.3

378.9

Effect of foreign currency translation

 

0.3

(1.2)

(3.0)

 

(5.2)

(9.1)

(2.7)

Total reported GAAP operating income

 

$313.6

$464.5

$548.9

$518.2

$1,845.2

$376.2

Notes:

We evaluate the performance of our non-U.S. dollar functional currency international operations based on fixed currency exchange rates, which eliminate the impact of exchange rate fluctuations on our international operations. Fixed currency amounts are updated annually at the beginning of each year based on translation into U.S. dollars at foreign currency exchange rates established by management, with all periods presented using such rates. Fixed currency rates are generally based on existing market rates at the time they are established.

The revised segment net sales and operating income for each of the three months ended March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, the twelve months ended December 31, 2019 and the three months ended March 31, 2020 reflect the ChampionX business as discontinued operations.

The above table includes financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”), including fixed currency sales and fixed currency operating income. We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results. These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in the table.


Exhibit 99.5

ECOLAB INC.

SUPPLEMENTAL NON-GAAP RECONCILIATIONS FOR THE THREE MONTHS ENDED
MARCH 31, 2020 AND FOR EACH OF THE TWELVE MONTHS ENDED DECEMBER 31, 2019 AND 2018

(unaudited)

(millions, except percent and per share)

  

Three Months Ended

Twelve Months Ended

Twelve Months Ended

March 31, 2020

  

December 31, 2019

  

December 31, 2018

Net sales

GAAP net sales from continuing operations

$3,020.6

$12,562.0

$12,222.1

Effect of foreign currency translation

19.2

35.4

(207.4)

Non-GAAP fixed currency sales from continuing operations

$3,039.8

$12,597.4

$12,014.7

Cost of sales

GAAP cost of sales from continuing operations

$1,720.2

$7,045.8

$6,875.3

Special (gains) and charges

9.1

38.5

4.8

Non-GAAP cost of sales from continuing operations

$1,711.1

$7,007.3

$6,870.5

Gross margin

GAAP gross margin from continuing operations

43.1

%

43.9

%

43.7

%

Non-GAAP adjusted gross margin from continuing operations

43.4

%

44.2

%

43.8

%

Operating income

GAAP operating income from continuing operations

$376.2

$1,845.2

$1,728.3

Effect of foreign currency translation

2.7

9.1

(26.5)

Non-GAAP fixed currency operating income from continuing operations

$378.9

$1,854.3

$1,701.8

GAAP operating income from continuing operations

$376.2

$1,845.2

$1,728.3

Special (gains) and charges

25.0

158.7

117.5

Non-GAAP adjusted operating income from continuing operations

401.2

2,003.9

1,845.8

Effect of foreign currency translation

2.7

9.1

(26.5)

Non-GAAP adjusted fixed currency operating income from continuing operations

$403.9

$2,013.0

$1,819.3

Operating income margin

GAAP operating income margin from continuing operations

12.5

%

14.7

%

14.1

%

Non-GAAP adjusted fixed currency operating income margin from continuing operations

13.3

%

16.0

%

15.1

%

Net Income attributable to Ecolab

GAAP net income from continuing operations attributable to Ecolab

$292.0

$1,425.6

$1,250.3

Special (gains) and charges, after tax

18.5

128.3

88.8

Discrete tax net expense (benefit)

(21.9)

(57.7)

2.1

Non-GAAP adjusted net income from continuing operations attributable to Ecolab

$288.6

$1,496.2

$1,341.2

Diluted Earnings per Share from continuing operations attributable to Ecolab

GAAP diluted EPS from continuing operations

$1.00

$4.87

$4.27

Special (gains) and charges, after tax

0.06

0.44

0.30

Discrete tax net expense (benefit)

(0.07)

(0.20)

0.01

Non-GAAP adjusted diluted EPS from continuing operations

$0.99

$5.12

$4.58

Note:

Per share amounts do not necessarily sum due to rounding.

The revised supplemental non-GAAP reconciliations reflect the ChampionX business as discontinued operations.

The above table includes financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”). We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive


compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.

The non-GAAP adjusted financial measures for cost of sales, gross margin and operating income exclude the impact of special (gains) and charges, and our non-GAAP measures for tax rate, net income attributable to Ecolab and diluted earnings per share further exclude the impact of discrete tax items. We include items within special (gains) and charges and discrete tax items that we believe can significantly affect the period-over-period assessment of operating results and not necessarily reflect costs associated with the historical trends and future results. After tax special (gains) and charges are derived by applying the applicable local jurisdictional tax rate to the corresponding pre-tax special (gains) and charges.

These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measure included in the table.